APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cefuroxime Powder For Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cefuroxime Powder For Injection Industry Growth and Trends Forecast to 2032

2 January 202696 pages

Choose your research edition.

Industry ResearchCefuroxime Powder For Injection Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Cefuroxime Powder For Injection Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Cefuroxime Powder For Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cefuroxime Powder For Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Cefuroxime Powder For Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cefuroxime Powder For Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cefuroxime Powder For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cefuroxime Powder For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cefuroxime Powder For Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cefuroxime Powder For Injection include GlaxoSmithKline (GSK), Fresenius Kabi, Lekhim, Flynn Pharma Ltd, Devatis Limited, Bowmed Ibisqus Limited, Biolab Co.,Ltd, AFT Pharmaceuticals and AdvaCare Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cefuroxime Powder For Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cefuroxime Powder For Injection market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cefuroxime Powder For Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cefuroxime Powder For Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cefuroxime Powder For Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cefuroxime Powder For Injection Market by Company

GlaxoSmithKline (GSK)

Fresenius Kabi

Lekhim

Flynn Pharma Ltd

Devatis Limited

Bowmed Ibisqus Limited

Biolab Co.,Ltd

AFT Pharmaceuticals

AdvaCare Pharma

Cefuroxime Powder For Injection Segment by Type

750 mg

250 mg

1.5 g

1 g

Cefuroxime Powder For Injection Segment by Application

Adult Use

Pediatric Use

Cefuroxime Powder For Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefuroxime Powder For Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cefuroxime Powder For Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefuroxime Powder For Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cefuroxime Powder For Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cefuroxime Powder For Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 750 mg Table 2. Major Company of 250 mg Table 3. Major Company of 1.5 g Table 4. Major Company of 1 g Table 5. Global Cefuroxime Powder For Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Cefuroxime Powder For Injection Sales by Type (2021-2026) & (Tons) Table 7. Global Cefuroxime Powder For Injection Sales Market Share in Volume by Type (2021-2026) Table 8. Global Cefuroxime Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 9. Global Cefuroxime Powder For Injection Sales Market Share in Value by Type (2021-2026) Table 10. Global Cefuroxime Powder For Injection Price by Type (2021-2026) & (US$/Kg) Table 11. Global Cefuroxime Powder For Injection Sales by Type (2027-2032) & (Tons) Table 12. Global Cefuroxime Powder For Injection Sales Market Share in Volume by Type (2027-2032) Table 13. Global Cefuroxime Powder For Injection Sales by Type (2027-2032) & (US$ Million) Table 14. Global Cefuroxime Powder For Injection Sales Market Share in Value by Type (2027-2032) Table 15. Global Cefuroxime Powder For Injection Price by Type (2027-2032) & (US$/Kg) Table 16. North America Cefuroxime Powder For Injection Sales by Type (2021-2026) & (Tons) Table 17. North America Cefuroxime Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Cefuroxime Powder For Injection Sales by Type (2021-2026) & (Tons) Table 19. Europe Cefuroxime Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Cefuroxime Powder For Injection Sales by Type (2021-2026) & (Tons) Table 21. Asia-Pacific Cefuroxime Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Cefuroxime Powder For Injection Sales by Type (2021-2026) & (Tons) Table 23. Latin America Cefuroxime Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Cefuroxime Powder For Injection Sales by Type (2021-2026) & (Tons) Table 25. Middle East and Africa Cefuroxime Powder For Injection Sales by Type (2021-2026) & (US$ Million) Table 26. Cefuroxime Powder For Injection Industry Trends Table 27. Cefuroxime Powder For Injection Industry Drivers Table 28. Cefuroxime Powder For Injection Industry Opportunities and Challenges Table 29. Cefuroxime Powder For Injection Industry Restraints Table 30. Global Cefuroxime Powder For Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Cefuroxime Powder For Injection Revenue Market Share by Company (2021-2026) Table 32. Global Cefuroxime Powder For Injection Sales by Company (2021-2026) & (Tons) Table 33. Global Cefuroxime Powder For Injection Sales Share by Company (2021-2026) Table 34. Global Cefuroxime Powder For Injection Market Price by Company (2021-2026) & (US$/Kg) Table 35. Global Cefuroxime Powder For Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Cefuroxime Powder For Injection Major Company Production Sites and Headquarters Table 37. Global Cefuroxime Powder For Injection Company, Product Type & Application Table 38. Global Cefuroxime Powder For Injection Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Cefuroxime Powder For Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Cefuroxime Powder For Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Cefuroxime Powder For Injection Sales by Region (2021-2026) & (Tons) Table 43. Global Cefuroxime Powder For Injection Sales Market Share in Volume by Region (2021-2026) Table 44. Global Cefuroxime Powder For Injection Sales by Region (2021-2026) & (US$ Million) Table 45. Global Cefuroxime Powder For Injection Sales Market Share in Value by Region (2021-2026) Table 46. Global Cefuroxime Powder For Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 47. Global Cefuroxime Powder For Injection Sales by Region (2027-2032) & (Tons) Table 48. Global Cefuroxime Powder For Injection Sales Market Share in Volume by Region (2027-2032) Table 49. Global Cefuroxime Powder For Injection Sales by Region (2027-2032) & (US$ Million) Table 50. Global Cefuroxime Powder For Injection Sales Market Share in Value by Region (2027-2032) Table 51. Global Cefuroxime Powder For Injection Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 52. Global Cefuroxime Powder For Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Cefuroxime Powder For Injection Sales by Application (2021-2026) & (Tons) Table 54. Global Cefuroxime Powder For Injection Sales Market Share in Volume by Application (2021-2026) Table 55. Global Cefuroxime Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 56. Global Cefuroxime Powder For Injection Sales Market Share in Value by Application (2021-2026) Table 57. Global Cefuroxime Powder For Injection Price by Application (2021-2026) & (US$/Kg) Table 58. Global Cefuroxime Powder For Injection Sales by Application (2027-2032) & (Tons) Table 59. Global Cefuroxime Powder For Injection Sales Market Share in Volume by Application (2027-2032) Table 60. Global Cefuroxime Powder For Injection Sales by Application (2027-2032) & (US$ Million) Table 61. Global Cefuroxime Powder For Injection Sales Market Share in Value by Application (2027-2032) Table 62. Global Cefuroxime Powder For Injection Price by Application (2027-2032) & (US$/Kg) Table 63. North America Cefuroxime Powder For Injection Sales by Application (2021-2026) & (Tons) Table 64. North America Cefuroxime Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Cefuroxime Powder For Injection Sales by Application (2021-2026) & (Tons) Table 66. Europe Cefuroxime Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Cefuroxime Powder For Injection Sales by Application (2021-2026) & (Tons) Table 68. Asia-Pacific Cefuroxime Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Cefuroxime Powder For Injection Sales by Application (2021-2026) & (Tons) Table 70. Latin America Cefuroxime Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Cefuroxime Powder For Injection Sales by Application (2021-2026) & (Tons) Table 72. Middle East and Africa Cefuroxime Powder For Injection Sales by Application (2021-2026) & (US$ Million) Table 73. GlaxoSmithKline (GSK) Company Information Table 74. GlaxoSmithKline (GSK) Business Overview Table 75. GlaxoSmithKline (GSK) Cefuroxime Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline (GSK) Cefuroxime Powder For Injection Product Portfolio Table 77. GlaxoSmithKline (GSK) Recent Development Table 78. Fresenius Kabi Company Information Table 79. Fresenius Kabi Business Overview Table 80. Fresenius Kabi Cefuroxime Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Fresenius Kabi Cefuroxime Powder For Injection Product Portfolio Table 82. Fresenius Kabi Recent Development Table 83. Lekhim Company Information Table 84. Lekhim Business Overview Table 85. Lekhim Cefuroxime Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Lekhim Cefuroxime Powder For Injection Product Portfolio Table 87. Lekhim Recent Development Table 88. Flynn Pharma Ltd Company Information Table 89. Flynn Pharma Ltd Business Overview Table 90. Flynn Pharma Ltd Cefuroxime Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Flynn Pharma Ltd Cefuroxime Powder For Injection Product Portfolio Table 92. Flynn Pharma Ltd Recent Development Table 93. Devatis Limited Company Information Table 94. Devatis Limited Business Overview Table 95. Devatis Limited Cefuroxime Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Devatis Limited Cefuroxime Powder For Injection Product Portfolio Table 97. Devatis Limited Recent Development Table 98. Bowmed Ibisqus Limited Company Information Table 99. Bowmed Ibisqus Limited Business Overview Table 100. Bowmed Ibisqus Limited Cefuroxime Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Bowmed Ibisqus Limited Cefuroxime Powder For Injection Product Portfolio Table 102. Bowmed Ibisqus Limited Recent Development Table 103. Biolab Co.,Ltd Company Information Table 104. Biolab Co.,Ltd Business Overview Table 105. Biolab Co.,Ltd Cefuroxime Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Biolab Co.,Ltd Cefuroxime Powder For Injection Product Portfolio Table 107. Biolab Co.,Ltd Recent Development Table 108. AFT Pharmaceuticals Company Information Table 109. AFT Pharmaceuticals Business Overview Table 110. AFT Pharmaceuticals Cefuroxime Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. AFT Pharmaceuticals Cefuroxime Powder For Injection Product Portfolio Table 112. AFT Pharmaceuticals Recent Development Table 113. AdvaCare Pharma Company Information Table 114. AdvaCare Pharma Business Overview Table 115. AdvaCare Pharma Cefuroxime Powder For Injection Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. AdvaCare Pharma Cefuroxime Powder For Injection Product Portfolio Table 117. AdvaCare Pharma Recent Development Table 118. North America Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 119. North America Cefuroxime Powder For Injection Sales by Country (2021-2026) & (Tons) Table 120. North America Cefuroxime Powder For Injection Sales Market Share by Country (2021-2026) Table 121. North America Cefuroxime Powder For Injection Sales Forecast by Country (2027-2032) & (Tons) Table 122. North America Cefuroxime Powder For Injection Sales Market Share Forecast by Country (2027-2032) Table 123. North America Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Cefuroxime Powder For Injection Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Cefuroxime Powder For Injection Market Share by Country (2021-2026) Table 126. North America Cefuroxime Powder For Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Cefuroxime Powder For Injection Market Share Forecast by Country (2027-2032) Table 128. Europe Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 129. Europe Cefuroxime Powder For Injection Sales by Country (2021-2026) & (Tons) Table 130. Europe Cefuroxime Powder For Injection Sales Market Share by Country (2021-2026) Table 131. Europe Cefuroxime Powder For Injection Sales Forecast by Country (2027-2032) & (Tons) Table 132. Europe Cefuroxime Powder For Injection Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Cefuroxime Powder For Injection Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Cefuroxime Powder For Injection Market Share by Country (2021-2026) Table 136. Europe Cefuroxime Powder For Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Cefuroxime Powder For Injection Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Cefuroxime Powder For Injection Sales by Country (2021-2026) & (Tons) Table 140. Asia-Pacific Cefuroxime Powder For Injection Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Cefuroxime Powder For Injection Sales Forecast by Country (2027-2032) & (Tons) Table 142. Asia-Pacific Cefuroxime Powder For Injection Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Cefuroxime Powder For Injection Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Cefuroxime Powder For Injection Market Share by Country (2021-2026) Table 146. Asia-Pacific Cefuroxime Powder For Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Cefuroxime Powder For Injection Market Share Forecast by Country (2027-2032) Table 148. Latin America Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 149. Latin America Cefuroxime Powder For Injection Sales by Country (2021-2026) & (Tons) Table 150. Latin America Cefuroxime Powder For Injection Sales Market Share by Country (2021-2026) Table 151. Latin America Cefuroxime Powder For Injection Sales Forecast by Country (2027-2032) & (Tons) Table 152. Latin America Cefuroxime Powder For Injection Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Cefuroxime Powder For Injection Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Cefuroxime Powder For Injection Market Share by Country (2021-2026) Table 156. Latin America Cefuroxime Powder For Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Cefuroxime Powder For Injection Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Cefuroxime Powder For Injection Sales by Country (2021-2026) & (Tons) Table 160. Middle East and Africa Cefuroxime Powder For Injection Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Cefuroxime Powder For Injection Sales Forecast by Country (2027-2032) & (Tons) Table 162. Middle East and Africa Cefuroxime Powder For Injection Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Cefuroxime Powder For Injection Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Cefuroxime Powder For Injection Market Share by Country (2021-2026) Table 166. Middle East and Africa Cefuroxime Powder For Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Cefuroxime Powder For Injection Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Cefuroxime Powder For Injection Distributors List Table 171. Cefuroxime Powder For Injection Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Cefuroxime Powder For Injection Image Figure 2. Global Cefuroxime Powder For Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cefuroxime Powder For Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Cefuroxime Powder For Injection Sales (2021-2032) & (Tons) Figure 5. 750 mg Image Figure 6. Global 750 mg Sales YoY Growth (2021-2032) & (Tons) Figure 7. 250 mg Image Figure 8. Global 250 mg Sales YoY Growth (2021-2032) & (Tons) Figure 9. 1.5 g Image Figure 10. Global 1.5 g Sales YoY Growth (2021-2032) & (Tons) Figure 11. 1 g Image Figure 12. Global 1 g Sales YoY Growth (2021-2032) & (Tons) Figure 13. Global Cefuroxime Powder For Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Cefuroxime Powder For Injection Market Share by Type 2025 VS 2032 Figure 15. North America Cefuroxime Powder For Injection Sales Market Share in Volume by Type in 2025 Figure 16. North America Cefuroxime Powder For Injection Sales Market Share in Value by Type in 2025 Figure 17. Europe Cefuroxime Powder For Injection Sales Market Share in Volume by Type in 2025 Figure 18. Europe Cefuroxime Powder For Injection Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Cefuroxime Powder For Injection Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Cefuroxime Powder For Injection Sales Market Share in Value by Type in 2025 Figure 21. Latin America Cefuroxime Powder For Injection Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Cefuroxime Powder For Injection Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Cefuroxime Powder For Injection Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Cefuroxime Powder For Injection Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Cefuroxime Powder For Injection Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adult Use Image Figure 28. Global Adult Use Sales YoY Growth (2021-2032) & (Tons) Figure 29. Pediatric Use Image Figure 30. Global Pediatric Use Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Cefuroxime Powder For Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cefuroxime Powder For Injection Market Share by Application 2025 VS 2032 Figure 33. North America Cefuroxime Powder For Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Cefuroxime Powder For Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Cefuroxime Powder For Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cefuroxime Powder For Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cefuroxime Powder For Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cefuroxime Powder For Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cefuroxime Powder For Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cefuroxime Powder For Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cefuroxime Powder For Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cefuroxime Powder For Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Cefuroxime Powder For Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Cefuroxime Powder For Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cefuroxime Powder For Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cefuroxime Powder For Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cefuroxime Powder For Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Cefuroxime Powder For Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cefuroxime Powder For Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cefuroxime Powder For Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cefuroxime Powder For Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Cefuroxime Powder For Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cefuroxime Powder For Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cefuroxime Powder For Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cefuroxime Powder For Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Cefuroxime Powder For Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cefuroxime Powder For Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cefuroxime Powder For Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cefuroxime Powder For Injection Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Cefuroxime Powder For Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cefuroxime Powder For Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cefuroxime Powder For Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cefuroxime Powder For Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cefuroxime Powder For Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 750 mg
  • 250 mg
  • 1.5 g
  • 1 g
Applications
  • Adult Use
  • Pediatric Use
Companies covered
  • GlaxoSmithKline (GSK)
  • Fresenius Kabi
  • Lekhim
  • Flynn Pharma Ltd
  • Devatis Limited
  • Bowmed Ibisqus Limited
  • Biolab Co.,Ltd
  • AFT Pharmaceuticals
  • AdvaCare Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cefuroxime Powder For Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cefuroxime Powder For Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cefuroxime Powder For Injection Market by Type
  6. 1.3.1 750 mg
  7. 1.3.2 250 mg
  8. 1.3.3 1.5 g
  9. 1.3.4 1 g
  10. 1.4 Global Cefuroxime Powder For Injection Market Size by Type
  11. 1.4.1 Global Cefuroxime Powder For Injection Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Cefuroxime Powder For Injection Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Cefuroxime Powder For Injection Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Cefuroxime Powder For Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Cefuroxime Powder For Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Cefuroxime Powder For Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Cefuroxime Powder For Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Cefuroxime Powder For Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cefuroxime Powder For Injection Industry Trends
  2. 2.2 Cefuroxime Powder For Injection Industry Drivers
  3. 2.3 Cefuroxime Powder For Injection Industry Opportunities and Challenges
  4. 2.4 Cefuroxime Powder For Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cefuroxime Powder For Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Cefuroxime Powder For Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Cefuroxime Powder For Injection Price (2021-2026)
  4. 3.4 Global Cefuroxime Powder For Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cefuroxime Powder For Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Cefuroxime Powder For Injection Company, Product Type & Application
  7. 3.7 Global Cefuroxime Powder For Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cefuroxime Powder For Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cefuroxime Powder For Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cefuroxime Powder For Injection Tier 1, Tier 2, and Tier 3
4 Cefuroxime Powder For Injection Regional Status and Outlook
  1. 4.1 Global Cefuroxime Powder For Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cefuroxime Powder For Injection Historic Market Size by Region
  3. 4.2.1 Global Cefuroxime Powder For Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cefuroxime Powder For Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cefuroxime Powder For Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cefuroxime Powder For Injection Forecasted Market Size by Region
  7. 4.3.1 Global Cefuroxime Powder For Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cefuroxime Powder For Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cefuroxime Powder For Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cefuroxime Powder For Injection by Application
  1. 5.1 Cefuroxime Powder For Injection Market by Application
  2. 5.1.1 Adult Use
  3. 5.1.2 Pediatric Use
  4. 5.2 Global Cefuroxime Powder For Injection Market Size by Application
  5. 5.2.1 Global Cefuroxime Powder For Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Cefuroxime Powder For Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Cefuroxime Powder For Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Cefuroxime Powder For Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Cefuroxime Powder For Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Cefuroxime Powder For Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Cefuroxime Powder For Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Cefuroxime Powder For Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GlaxoSmithKline (GSK)
  2. 6.1.1 GlaxoSmithKline (GSK) Company Information
  3. 6.1.2 GlaxoSmithKline (GSK) Business Overview
  4. 6.1.3 GlaxoSmithKline (GSK) Cefuroxime Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GlaxoSmithKline (GSK) Cefuroxime Powder For Injection Product Portfolio
  6. 6.1.5 GlaxoSmithKline (GSK) Recent Developments
  7. 6.2 Fresenius Kabi
  8. 6.2.1 Fresenius Kabi Company Information
  9. 6.2.2 Fresenius Kabi Business Overview
  10. 6.2.3 Fresenius Kabi Cefuroxime Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Fresenius Kabi Cefuroxime Powder For Injection Product Portfolio
  12. 6.2.5 Fresenius Kabi Recent Developments
  13. 6.3 Lekhim
  14. 6.3.1 Lekhim Company Information
  15. 6.3.2 Lekhim Business Overview
  16. 6.3.3 Lekhim Cefuroxime Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Lekhim Cefuroxime Powder For Injection Product Portfolio
  18. 6.3.5 Lekhim Recent Developments
  19. 6.4 Flynn Pharma Ltd
  20. 6.4.1 Flynn Pharma Ltd Company Information
  21. 6.4.2 Flynn Pharma Ltd Business Overview
  22. 6.4.3 Flynn Pharma Ltd Cefuroxime Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Flynn Pharma Ltd Cefuroxime Powder For Injection Product Portfolio
  24. 6.4.5 Flynn Pharma Ltd Recent Developments
  25. 6.5 Devatis Limited
  26. 6.5.1 Devatis Limited Company Information
  27. 6.5.2 Devatis Limited Business Overview
  28. 6.5.3 Devatis Limited Cefuroxime Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Devatis Limited Cefuroxime Powder For Injection Product Portfolio
  30. 6.5.5 Devatis Limited Recent Developments
  31. 6.6 Bowmed Ibisqus Limited
  32. 6.6.1 Bowmed Ibisqus Limited Company Information
  33. 6.6.2 Bowmed Ibisqus Limited Business Overview
  34. 6.6.3 Bowmed Ibisqus Limited Cefuroxime Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bowmed Ibisqus Limited Cefuroxime Powder For Injection Product Portfolio
  36. 6.6.5 Bowmed Ibisqus Limited Recent Developments
  37. 6.7 Biolab Co.,Ltd
  38. 6.7.1 Biolab Co.,Ltd Company Information
  39. 6.7.2 Biolab Co.,Ltd Business Overview
  40. 6.7.3 Biolab Co.,Ltd Cefuroxime Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biolab Co.,Ltd Cefuroxime Powder For Injection Product Portfolio
  42. 6.7.5 Biolab Co.,Ltd Recent Developments
  43. 6.8 AFT Pharmaceuticals
  44. 6.8.1 AFT Pharmaceuticals Company Information
  45. 6.8.2 AFT Pharmaceuticals Business Overview
  46. 6.8.3 AFT Pharmaceuticals Cefuroxime Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AFT Pharmaceuticals Cefuroxime Powder For Injection Product Portfolio
  48. 6.8.5 AFT Pharmaceuticals Recent Developments
  49. 6.9 AdvaCare Pharma
  50. 6.9.1 AdvaCare Pharma Company Information
  51. 6.9.2 AdvaCare Pharma Business Overview
  52. 6.9.3 AdvaCare Pharma Cefuroxime Powder For Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AdvaCare Pharma Cefuroxime Powder For Injection Product Portfolio
  54. 6.9.5 AdvaCare Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Cefuroxime Powder For Injection Sales by Country
  2. 7.1.1 North America Cefuroxime Powder For Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cefuroxime Powder For Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Cefuroxime Powder For Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cefuroxime Powder For Injection Market Size by Country
  6. 7.2.1 North America Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cefuroxime Powder For Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Cefuroxime Powder For Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cefuroxime Powder For Injection Sales by Country
  2. 8.1.1 Europe Cefuroxime Powder For Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cefuroxime Powder For Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Cefuroxime Powder For Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cefuroxime Powder For Injection Market Size by Country
  6. 8.2.1 Europe Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cefuroxime Powder For Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cefuroxime Powder For Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cefuroxime Powder For Injection Sales by Country
  2. 9.1.1 Asia-Pacific Cefuroxime Powder For Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cefuroxime Powder For Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cefuroxime Powder For Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cefuroxime Powder For Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cefuroxime Powder For Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cefuroxime Powder For Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cefuroxime Powder For Injection Sales by Country
  2. 10.1.1 South America Cefuroxime Powder For Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cefuroxime Powder For Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Cefuroxime Powder For Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cefuroxime Powder For Injection Market Size by Country
  6. 10.2.1 South America Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cefuroxime Powder For Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Cefuroxime Powder For Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cefuroxime Powder For Injection Sales by Country
  2. 11.1.1 Middle East and Africa Cefuroxime Powder For Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cefuroxime Powder For Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cefuroxime Powder For Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cefuroxime Powder For Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Cefuroxime Powder For Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cefuroxime Powder For Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cefuroxime Powder For Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cefuroxime Powder For Injection Value Chain Analysis
  2. 12.1.1 Cefuroxime Powder For Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cefuroxime Powder For Injection Production Mode & Process
  7. 12.2 Cefuroxime Powder For Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cefuroxime Powder For Injection Distributors
  10. 12.2.3 Cefuroxime Powder For Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst